An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol.

ABSTRACT:

Background

Atrial fibrillation (AF) is an independent risk factor for stroke and a significant predictor of mortality. Evidence-based guidelines for stroke prevention in AF recommend antithrombotic therapy corresponding to the risk of stroke. In practice, many patients with AF do not receive the appropriate antithrombotic therapy and are left either unprotected or inadequately protected against stroke. The purpose of the Global Anticoagulant Registry in the FIELD (GARFIELD) is to determine the real-life management and outcomes of patients newly diagnosed with non-valvular AF.

Methods/design

GARFIELD is an observational, international registry of newly diagnosed AF patients with at least one additional investigator-defined risk factor for stroke. The aim is to enrol 55,000 pa

SUBMITTER: Apenteng PN 

PROVIDER: S-EPMC3639953 | biostudies-literature | 2013 Apr

REPOSITORIES: biostudies-literature